Remove Bacteria Remove Contamination Remove Research Remove Scientist
article thumbnail

Scientists engineer safe, virus-resistant E coli for research

Drug Discovery World

In a step forward for genetic engineering and synthetic biology, US researchers have modified E coli bacteria to be immune to infection by all natural viruses tested so far. The team used two safeguard methods to prevent the bacteria and their modified genes from escaping into the wild.

article thumbnail

New Rapid Salmonella Test Could Accelerate Poultry Safety

XTalks

Researchers at McMaster University in Canada have developed a rapid Salmonella test for detecting contamination in chicken and other foods, which could help to reduce the cost of food processing and improve food safety. In the US alone, the bacteria is estimated to cause around 1.35

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chameleon-Inspired Color-Changing Material Can Be a Game-Changer for Seafood Safety

XTalks

A team of scientists in China and Germany designed an artificial material , inspired by chameleon skin, that can detect the freshness of seafood by changing colors. Related: MIT Scientists Develop Food Sensor That Can Detect Spoiled or Contaminated Food. So how does it work? to reach $28.6 billion by 2026. . “The

article thumbnail

Improving quality control for CAR T cell therapies

Drug Discovery World

But decades of research led to improvements in cancer therapy, centred around the idea that one’s immune system could aid in treatment. Their continued promise has led to an exponential increase in research on their utility, function, risks, and potential benefits. Developing the first CAR T cell therapy.

article thumbnail

Advances in cell line development

Drug Discovery World

According to Grand View Research, the global cell line development market was valued at $4.81 Grand View Research states that the market for cell lines is currently bolstered by the fact that the majority of biopharma companies use cell lines to synthesise recombinant monoclonal antibodies and proteins.